Back to results
CompletedPhase 2

A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis

NCT02035553

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

London, United Kingdom

View on ClinicalTrials.gov
A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis — TrialFind